New Delhi, India

Achla Behl Khanna

This inventor holds 2 USPTO granted patents. Top assignee: Dabur Research Foundation. Active years: 2001-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Achla Behl Khanna. Retrieved from https://idiyas.com/inventor/achla-behl-khanna

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Location History:

  • Delhi, IN (2001)
  • New Deli, IN (2003)

Company Filing History:


Years Active: 2001-2003

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Achla Behl Khanna: Innovator in Cancer Research

Introduction

Achla Behl Khanna is a prominent inventor based in New Delhi, India. She has made significant contributions to the field of cancer research, particularly through her innovative work on betulinic acid derivatives. With a total of two patents to her name, her inventions focus on the inhibition and prevention of cancer growth.

Latest Patents

Achla Behl Khanna's latest patents include "Betulinic acid derivatives for inhibiting cancer growth" and "Process for the manufacture of betulinic acid." These inventions relate to the use of betulinic acid derivatives for the inhibition and prevention of cancer growth. They also explore novel derivatives that are effective against tumor cancer cells. Furthermore, her work highlights the anti-leukemic and anti-lymphoma activities of these derivatives, which can be utilized in the treatment of various cancers, including prostate, lung, laryngeal, colon, and ovarian cancer.

Career Highlights

Achla Behl Khanna is associated with the Dabur Research Foundation, where she continues her research and development efforts. Her work has garnered attention for its potential impact on cancer treatment and prevention.

Collaborations

Achla has collaborated with notable colleagues such as Sunder Ramadoss and Manu Jaggi, contributing to a dynamic research environment focused on innovative solutions in cancer therapy.

Conclusion

Achla Behl Khanna's contributions to cancer research through her patents on betulinic acid derivatives demonstrate her commitment to advancing medical science. Her work holds promise for improving treatment options for cancer patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…